Skip to main content

Table 1 Clinical characteristics of study group

From: UGT1A1 gene and neonatal hyperbilirubinemia: a preliminary study from Bengkulu, Indonesia

Descriptive variables

Case, n(%)

Control, n(%)

OR

95% CI

p-value

N = 30

N = 11

Sex

 Male

10 (33.3%)

4 (36.4%)

0.875

0.170–5.093

1.000

 Female

20 (67%)

7 (63.6%)

   

Gestational age (week)

 Range

27–40

30–38

N/A

N/A

0.5290

 Mean

35.4

34.6

   

Birth weight (g)

 Range

1200–3700

1200–3700

N/A

N/A

0.5839

 Mean

2360.66

2209.1

   

Total plasma bilirubin (mg/dL)

 Range

15.2–29

8.8–14.7

N/A

N/A

0.0000

 Mean

20.38

12.3

   

Feeding

 Exclusive breastfeeding

18 (60%)

8 (72.7%)

1.77778

0.329–12.347

0.7158

 Not exclusive breastfeeding

12 (40%)

3 (27.3%)

   

Delivery method

 Vaginal

15 (50%)

7 (63.6%)

1.75

0.348–9.829

0.4993

 Cesarean

15 (50%)

4 (36.4%)

   

Sibling history for hyperbilirubinemia requiring phototherapy

 Yes

1 (3.33%)

2 (18.2%)

0.1551724

0.003–3.491

0.1703

 No

29 (96.67%)

9 (81.8%)

   

Born to primipara mother

 Yes

15 (50%)

3 (27.3%)

2.6667

0.497–18.229

0.2911

 No

15 (50%)

8 (72.7%)